NCT03287505View on ClinicalTrials.gov

Aripiprazole IM Depot for Chinese Patients With Schizophrenia

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 23, 2017

Primary Completion Date

November 8, 2019

Study Completion Date

November 8, 2019

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole IM Depot

administration of Aripiprazole IM Depot formulation at doses of 300 and 400mg once in patients with schizophrenia.

Trial Locations (1)

100088

Beijing Anding Hospital of Capital Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Otsuka Beijing Research Institute

INDUSTRY